Febrile
6
0
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
16.7%
1 terminated out of 6 trials
75.0%
-11.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Clinical Accuracy Validation of the Moni-Patch Temperature Monitoring Patch System
The Clinical Performance Validation of Electronic Thermometer and Infrared Thermometers
A Clinical Data Collection Study of Verily Patch
Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice
Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia
Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia